Cellular and circuitry mechanisms of NRTI-induced pain pathogenesis in the context of opioids and HIV
阿片类药物和 HIV 背景下 NRTI 诱导的疼痛发病机制的细胞和电路机制
基本信息
- 批准号:10704142
- 负责人:
- 金额:$ 56.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAblationAdjuvant TherapyAnti-Retroviral AgentsAstrocytesBehaviorBehavioralCell physiologyCellsCentral Nervous SystemComplicationDataDevelopmentExposure toGanciclovirGlial Fibrillary Acidic ProteinHIVHIV Envelope Protein gp120HIV-1HIV/AIDSHighly Active Antiretroviral TherapyHyperalgesiaIntegrase InhibitorsInterleukin-1 betaKnock-outKnowledgeLamivudineMeasuresMicrogliaMitochondriaMitochondrial DNAMorphineMusNeurologicNeuropathogenesisNucleosidesOpioidPainPathogenesisPathogenicityPathologicPathway AnalysisPatientsPersonsPharmaceutical PreparationsProcessProductionPropertyProtease InhibitorProteinsQuality of lifeReactionReactive Oxygen SpeciesRegimenResearchReverse Transcriptase InhibitorsRoleSOD2 geneSpinalSpinal CordSynapsesSynaptic plasticitySyndromeTNF geneTenofovirTestingToxic effectToxinTransgenic MiceTransgenic OrganismsVertebral columnVirus DiseasesVirus ReplicationZalcitabineZidovudineallodyniaantiretroviral therapybehavior testconditional knockoutdorsal hornemtricitabineexperimental studyglial activationinsightneural circuitneuroAIDSneuroinflammationnon-nucleoside reverse transcriptase inhibitorsopioid useopioid use disorderoverexpressionpain behaviorpain sensationpainful neuropathypostsynapticsingle nucleus RNA-sequencingsingle-cell RNA sequencingtranscriptomicstransmission processviral transmission
项目摘要
PROJECT SUMMARY
Combination antiretroviral therapy (cART) is the current first-line treatment for human immunodeficiency virus
(HIV) infection. Unfortunately, cART is implicated in various forms of HIV-associated neurological disorders. Pain
is the most common neurological complication that significantly reduces the quality of life of many people living
with HIV (PLWH), and emerging evidence suggests cART critically contributes to the development of pain in
PLWH. However, the mechanism by which cART promotes pain pathogenesis is still incompletely understood
and rationale-based effective adjuvant therapy is not available. In this project, we aim to elucidate the pathogenic
mechanism of nucleoside reverse transcriptase inhibitors (NRTIs), which are the cornerstone antiretroviral drugs
in cART regimens and induce neuropathic pain. Because PLWH on cART are commonly exposed to opioids and
HIV-1 gp120 protein that causes pain, we will also investigate the potential pathogenic interaction between
NRTIs and opioids or gp120. Our data show that separate administration of NRTIs, morphine, or gp120 to mice
causes pathological pain, and that the development of pathological pain induced by these agents shares
mechanistic properties with the activation of glial cells in the spinal dorsal horn. We hypothesize that NRTIs
promote pain pathogenesis in the neural circuit via glial activation and that gp120 and opioids can exacerbate
this condition. We will test this hypothesis by performing: (1) single cell transcriptomic analysis to characterize
the cellular neuropathogenesis induced by NRTIs in conjunction with opioids or gp120 (Aim 1), (2) whole cell
patch recording to characterize the pathologic pain neural circuitry induced by NRTIs with opioids or gp120 (Aim
2), and (3) behavioral testing to characterize pathological pain induced by NRTIs with opioids or gp120 (Aim 3).
Results from this research will help to define the potential detrimental impact of cART on the CNS and its
interactions with HIV and opioids.
项目摘要
抗逆转录病毒疗法(CART)是目前针对人类免疫缺陷病毒的一线治疗
(HIV)感染。不幸的是,购物车与各种形式的HIV相关神经系统疾病有关。疼痛
是最常见的神经系统并发症,大大降低了许多生活的人的生活质量
与艾滋病毒(PLWH)和新兴证据一起表明,卡车对疼痛的发展有助于
plwh。然而,手推车促进疼痛发病机理的机制仍未完全理解
基于基本原理的有效辅助疗法不可用。在这个项目中,我们旨在阐明致病性
核苷逆转录酶抑制剂(NRTIS)的机理,它是基石抗逆转录病毒药物
在购物车方案中诱发神经性疼痛。因为购物车上的PLWH通常暴露于阿片类药物中,并且
引起疼痛的HIV-1 GP120蛋白,我们还将研究
NRTIS和阿片类药物或GP120。我们的数据表明,将NRTI,吗啡或GP120分开给小鼠施用
引起病理疼痛,并且这些药物诱导的病理疼痛的发展
机械特性,具有脊柱背角中神经胶质细胞的激活。我们假设NRTI
通过神经胶质激活促进神经回路中的疼痛发病机理,而GP120和阿片类药物会加剧
这种情况。我们将通过执行:(1)单细胞转录组分析来检验此假设以表征
NRTI与阿片类药物或GP120诱导的细胞神经病发生(AIM 1),(2)全细胞
贴片记录以表征由阿片类药物或GP120诱导的病理疼痛神经回路(AIM
2)和(3)行为测试以表征由阿片类药物或GP120诱导的病理疼痛(AIM 3)。
这项研究的结果将有助于定义购物车对中枢神经系统及其ITS的潜在有害影响
与艾滋病毒和阿片类药物的相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAO-JUN TANG其他文献
SHAO-JUN TANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAO-JUN TANG', 18)}}的其他基金
Cellular and circuitry mechanisms of NRTI-induced pain pathogenesis in the context of opioids and HIV
阿片类药物和 HIV 背景下 NRTI 诱导的疼痛发病机制的细胞和电路机制
- 批准号:
10559782 - 财政年份:2022
- 资助金额:
$ 56.92万 - 项目类别:
Antiretroviral Therapy and Neuroinflammation in the CNS
抗逆转录病毒治疗和中枢神经系统神经炎症
- 批准号:
9357679 - 财政年份:2016
- 资助金额:
$ 56.92万 - 项目类别:
Antiretroviral Therapy and Neuroinflammation in the CNS
抗逆转录病毒治疗和中枢神经系统神经炎症
- 批准号:
9271670 - 财政年份:2016
- 资助金额:
$ 56.92万 - 项目类别:
Interplay of HIV-1 gp120 and opioids in astrocyte activation
HIV-1 gp120 和阿片类药物在星形胶质细胞激活中的相互作用
- 批准号:
8584926 - 财政年份:2013
- 资助金额:
$ 56.92万 - 项目类别:
Interplay of HIV-1 gp120 and opioids in astrocyte activation
HIV-1 gp120 和阿片类药物在星形胶质细胞激活中的相互作用
- 批准号:
8719076 - 财政年份:2013
- 资助金额:
$ 56.92万 - 项目类别:
Interplay of HIV-1 gp120 and opioids in astrocyte activation
HIV-1 gp120 和阿片类药物在星形胶质细胞激活中的相互作用
- 批准号:
9084524 - 财政年份:2013
- 资助金额:
$ 56.92万 - 项目类别:
Interplay of HIV-1 gp120 and opioids in astrocyte activation
HIV-1 gp120 和阿片类药物在星形胶质细胞激活中的相互作用
- 批准号:
8840924 - 财政年份:2013
- 资助金额:
$ 56.92万 - 项目类别:
Interplay of HIV-1 gp120 and opioids in astrocyte activation
HIV-1 gp120 和阿片类药物在星形胶质细胞激活中的相互作用
- 批准号:
9265050 - 财政年份:2013
- 资助金额:
$ 56.92万 - 项目类别:
Wnt signaling in glial activation during HIV-associated chronic pain pathogenesis
HIV相关慢性疼痛发病机制中神经胶质激活中的Wnt信号传导
- 批准号:
8846150 - 财政年份:2012
- 资助金额:
$ 56.92万 - 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
- 批准号:82373219
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
- 批准号:32300701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
- 批准号:82302332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Steerable Laser Interstitial Thermotherapy (SLIT) Robot for Brain Tumor Therapy
用于脑肿瘤治疗的可操纵激光间质热疗 (SLIT) 机器人
- 批准号:
10572533 - 财政年份:2023
- 资助金额:
$ 56.92万 - 项目类别:
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
新辅助免疫放疗治疗 HPV 介导的口咽癌
- 批准号:
10682257 - 财政年份:2023
- 资助金额:
$ 56.92万 - 项目类别:
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs
青蒿琥酯改善中低收入国家 HIV 阳性女性 HPV 和宫颈癌前治疗结果的可行性
- 批准号:
10762866 - 财政年份:2023
- 资助金额:
$ 56.92万 - 项目类别:
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma
整合成像和活检衍生的分子标记物,用于惰性和侵袭性早期肺腺癌的术前检测
- 批准号:
10737330 - 财政年份:2023
- 资助金额:
$ 56.92万 - 项目类别: